Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

NCT04142151 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Antiplatelet Effect

Interventions

DRUG: Sanchitongshu
DRUG: Aspirin
DRUG: Clopidogrel
DRUG: placebo of Sanchitongshu

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine